Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kristin Stafford files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kenneth Galbraith - $3.34M in ZYME purchases and sales in the last 12 months
- William F. Doyle - $933K in NVCR purchases and sales in the last 12 months
- Frank X. Leonard - $920K in NVCR purchases and sales in the last 12 months
- Paul Andrew Moore - $721K in ZYME purchases and sales in the last 12 months
- Mukund Paravasthu - $694K in NVCR purchases and sales in the last 12 months
- Jeffrey T. L. Smith - $476K in ZYME purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kristin Stafford?
Kristin Stafford is a corporate insider of NovoCure Ltd (NVCR). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Kristin Stafford last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 3 filings going back to 2026.
Has Kristin Stafford been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($46K) across all tracked filings.
